These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15475248)

  • 1. Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15.
    Wilson W; Pardo-Manuel de Villena F; Lyn-Cook BD; Chatterjee PK; Bell TA; Detwiler DA; Gilmore RC; Valladeras IC; Wright CC; Threadgill DW; Grant DJ
    Genomics; 2004 Oct; 84(4):707-14. PubMed ID: 15475248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
    Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.
    Ménard V; Eap O; Harvey M; Guillemette C; Lévesque E
    Hum Mutat; 2009 Sep; 30(9):1310-9. PubMed ID: 19572376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4.
    Turgeon D; Carrier JS; Lévesque E; Beatty BG; Bélanger A; Hum DW
    J Mol Biol; 2000 Jan; 295(3):489-504. PubMed ID: 10623541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution.
    Dubois SG; Beaulieu M; Lévesque E; Hum DW; Bélanger A
    J Mol Biol; 1999 May; 289(1):29-39. PubMed ID: 10339403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
    Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme.
    Beaulieu M; Lévesque E; Tchernof A; Beatty BG; Bélanger A; Hum DW
    DNA Cell Biol; 1997 Oct; 16(10):1143-54. PubMed ID: 9364925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization of the UGT2b gene cluster on human chromosome 4q13.
    Riedy M; Wang JY; Miller AP; Buckler A; Hall J; Guida M
    Pharmacogenetics; 2000 Apr; 10(3):251-60. PubMed ID: 10803681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.
    Gallagher CJ; Kadlubar FF; Muscat JE; Ambrosone CB; Lang NP; Lazarus P
    Cancer Detect Prev; 2007; 31(4):310-5. PubMed ID: 17935910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.
    Zhu AZ; Cox LS; Ahluwalia JS; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2015 May; 25(5):263-9. PubMed ID: 25794161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis.
    Yang TL; Chen XD; Guo Y; Lei SF; Wang JT; Zhou Q; Pan F; Chen Y; Zhang ZX; Dong SS; Xu XH; Yan H; Liu X; Qiu C; Zhu XZ; Chen T; Li M; Zhang H; Zhang L; Drees BM; Hamilton JJ; Papasian CJ; Recker RR; Song XP; Cheng J; Deng HW
    Am J Hum Genet; 2008 Dec; 83(6):663-74. PubMed ID: 18992858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y).
    Lampe JW; Bigler J; Bush AC; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):329-33. PubMed ID: 10750673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of UGT2B17 deletion polymorphism on prognosis in pediatric cancer.
    Ishimaru S; Yuza Y; Kaneko T; Urashima M
    Pediatr Int; 2017 Apr; 59(4):427-431. PubMed ID: 27805301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
    Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
    J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data.
    Novillo A; Gaibar M; Romero-Lorca A; Chaabani H; Amir N; Moral P; Esteban ME; Fernández-Santander A
    Ann Hum Biol; 2018; 45(6-8):516-523. PubMed ID: 30616396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.
    Angstadt AY; Berg A; Zhu J; Miller P; Hartman TJ; Lesko SM; Muscat JE; Lazarus P; Gallagher CJ
    Cancer; 2013 Jul; 119(13):2477-85. PubMed ID: 23575887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UGT2B17 gene deletion is not associated with prostate cancer risk.
    Olsson M; Lindström S; Häggkvist B; Adami HO; Bälter K; Stattin P; Ask B; Rane A; Ekström L; Grönberg H
    Prostate; 2008 Apr; 68(5):571-5. PubMed ID: 18247404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.